At a glance
- Originator Ikedo Mohando
- Developer Grelan Pharmaceutical; Ikedo Mohando
- Class Antihistamines; Antisecretories; Antiulcers; Small molecules
- Mechanism of Action Histamine H2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Duodenal ulcer
Most Recent Events
- 12 Jun 2000 No-Development-Reported for Duodenal ulcer in Japan (PO)
- 30 Jul 1997 Phase-II clinical trials for Duodenal ulcer in Japan (PO)
- 15 Dec 1995 Phase-II clinical trials for Duodenal ulcer in Japan (Unknown route)